BEAT
Heartbeam, Inc. Common Stock
stockNASDAQ
heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient's 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.37 | 2026-09-28 | +91.93% | 5.939 |
| 1M | 0.43 | 2026-09-04 | +67.74% | 2.798 |
| 3M | 0.69 | 2026-07-06 | +3.60% | 2.194 |
| 6M | 1.20 | 2026-04-06 | -40.34% | 2.120 |
| 1Y | 1.86 | 2025-10-06 | -61.51% | 1.753 |
| 2Y | 2.19 | 2024-10-04 | -67.31% | — |
| 5Y | 4.69 | 2021-11-11 | -84.74% | 1.070 |
Heartbeam, Inc. Common Stock (NASDAQ:BEAT) stock price today is $0.72, and today's volume is 157,140,311. BEAT is up 64.726% today. The 30 day average volume is 440,047. BEAT market cap is $40.34M with 56.35M shares outstanding.